NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 983.55
+22.10 (2.30%)
At close: Jul 10, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 176.26 billion as of July 13, 2026. Its market cap has increased by 12.46% in one year.
Market Cap
176.26B
Enterprise Value
162.11B
Revenue
40.78B
Ranking
n/a
PE Ratio
12.43
Stock Price
983.55
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 176.26B, an increase of 40,949.54%. That is a compound annual growth rate of 24.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 175.52B | 8.52% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |
| Caplin Point Laboratories | 196.52B |
| Jubilant Pharmova | 152.20B |
| CORONA Remedies | 124.94B |